The differences in the frequencies of other common AML biomarkers (including NPM1, DNMT3A, IDH1, IDH2, TP53, KRAS, NRAS, RUNX1, and CEBPA) between the South Korean and other cohorts were not significant. The gene discussed is KRAS; the disease is acute myeloid leukemia.